Hand-Foot-Mouth Disease: Viral Exanthem in Children

Overview of Hand-Foot-Mouth Disease

Hand-foot-mouth disease (HFMD) is a common viral infection affecting primarily young children caused most frequently by coxsackievirus A16 and enterovirus 71 (EV-71). The disease is characterized by a distinctive distribution of painful oral ulcers, and a vesicular rash on the hands and feet. HFMD occurs most commonly in children under 5 years of age but can affect older children and adults, particularly in epidemic periods. The condition is highly contagious, spreading through respiratory droplets and fecal-oral routes, making it common in daycare and school settings during late summer and fall months. While HFMD is generally self-limited and mild in immunocompetent children, enterovirus 71 has been associated with more severe disease including neurological complications and myocarditis, particularly in Asian populations.

Etiology and Epidemiology

HFMD is caused by enteroviruses, with coxsackievirus A16 being the most common causative agent globally, followed by enterovirus 71 (EV-71). Other coxsackieviruses including A5, A6, A9, A10, and A22 may occasionally cause HFMD. Enterovirus 71 is notable because it has been associated with severe disease, neurological manifestations, and mortality in some outbreaks, particularly in the Asia-Pacific region. Transmission occurs through respiratory droplets, contact with infected oral secretions, and fecal-oral contamination. The virus can be recovered from stool for weeks after clinical illness, allowing prolonged fecal transmission. HFMD occurs year-round in tropical and subtropical climates but shows a seasonal peak in late summer and fall in temperate regions. The incubation period is typically 3-6 days (range 2-10 days). Most cases occur in children under 5 years, though older children and adults may be infected, particularly in epidemic periods.

Clinical Presentation and Manifestations

HFMD typically begins with fever, malaise, reduced appetite, and sore mouth lasting 1-2 days. Oral ulcers then develop on the anterior two-thirds of the tongue, hard palate, buccal mucosa, and gums, appearing initially as small red macules that progress to painful vesicles and shallow ulcers. These oral lesions are distinctive in their sharp demarcation and central ulceration surrounded by erythema, causing pain with eating and drinking. Simultaneously or shortly after oral lesions develop, a characteristic vesicular rash appears on the palms and soles, typically on the sides and tips of fingers and toes. The rash may also involve the dorsal surfaces of the hands and feet. These vesicles are typically smaller than those seen in varicella, more uniform in appearance, and non-pruritic. The rash may spread to the buttocks, genitals, and lower extremities in some cases, and may occasionally involve other body areas. Systemic symptoms usually resolve within 3-5 days, though oral ulcers may persist 7-10 days.

Complications and Severity

While most cases of HFMD are mild and self-limited, complications can occur, particularly with enterovirus 71 infection. Severe dehydration may develop due to oral pain limiting fluid intake, necessitating intravenous hydration in severe cases. Neurological complications including aseptic meningitis, brainstem encephalitis, and myelitis have been reported with EV-71 infection, particularly in young children. These serious neurological complications carry risk of long-term morbidity or mortality. Myocarditis and cardiopulmonary complications have been documented. Pulmonary edema and severe systemic disease were reported during major EV-71 outbreaks in Asia in 1997-1998. Secondary bacterial infection of vesicles and ulcers may occur but is generally self-limited. Most immunocompetent children with HFMD caused by coxsackievirus A16 experience only mild disease and recover completely within 7-10 days without sequelae.

Diagnosis and Differential Diagnosis

Diagnosis is primarily clinical based on the distinctive presentation of oral ulcers combined with vesicular rash on hands and feet. The characteristic distribution and appearance typically allow diagnosis without additional testing. Viral culture from throat swabs, stool, or vesicular fluid can identify the causative enterovirus but is not routinely performed. PCR testing for enterovirus can provide rapid molecular diagnosis when confirmation is desired. Serology can demonstrate acute infection with rising antibody titers but is not typically useful clinically. The differential diagnosis includes herpetic stomatitis (painful oral ulcers but typically more severe, no hand-foot rash), varicella (vesicular rash more widespread and pruritic), and erythema multiforme (different lesion morphology and distribution). The combination of oral ulcers with acral vesicular rash is distinctive for HFMD and usually allows accurate diagnosis without testing.

Management and Treatment

Management of HFMD is supportive, as no specific antiviral therapy is indicated for immunocompetent patients with mild disease. Treatment focuses on pain management with acetaminophen or ibuprofen, adequate hydration, and nutritional support. For oral pain, topical anesthetics such as benzocaine gels or viscous lidocaine may provide temporary relief, though systemic analgesics are more effective. Bland, soft foods and cool beverages should be offered to maintain nutrition and hydration. If significant dehydration develops, intravenous fluid therapy may be necessary. Antiviral therapy with pleconaril has been studied experimentally for severe EV-71 disease but is not FDA-approved and not routinely available. Supportive care remains the mainstay of treatment. Children may return to school or daycare once fever resolves and they feel well enough to participate, though transmission risk remains as long as virus is shed in stool. Standard precautions including hand hygiene help reduce transmission.

Prevention and Infection Control

HFMD prevention relies on standard infection control measures. Hand hygiene with soap and water, particularly after diaper changes and toilet use, reduces transmission via the fecal-oral route. Respiratory hygiene including covering coughs and sneezes limits droplet spread. Contaminated surfaces should be cleaned with appropriate disinfectants. Exclusion of sick children from childcare until fever resolves helps limit spread in group settings. No vaccines are currently available for coxsackievirus A16 or most other HFMD-causing enteroviruses, though vaccine development efforts continue. Inactivated EV-71 vaccines have been developed and used in China to prevent severe disease from that particular enterovirus.

Frequently Asked Questions

Is this similar to foot-and-mouth disease in animals? No. Despite the similar name, HFMD in humans is distinct from the foot-and-mouth disease affecting cattle. They are different diseases caused by different viruses.

How long will the rash last? The vesicular rash typically resolves within 7-10 days without scarring. Oral ulcers may persist somewhat longer but eventually resolve completely.

Is my child contagious while having HFMD? Yes. The virus is present in respiratory secretions and stool, with stool being contagious for several weeks after symptom resolution.

Will the rash scar? No. HFMD rashes are superficial vesicles that resolve without scarring or permanent skin changes.

When should I worry about serious complications? Contact your physician if your child shows neurological symptoms, extreme lethargy, severe respiratory distress, or inability to maintain adequate hydration.

References